FDA
approval
· 2020-02-20
FDA Approved: VIBATIV — Supplemental Application (Cumberland Pharmaceuticals Inc.)
Summary
FDA approved a supplemental application for VIBATIV (telavancin hydrochloride) from Cumberland Pharmaceuticals Inc. The approval indicates the supplemental subm…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for VIBATIV (TELAVANCIN HYDROCHLORIDE)